以色列 - 希伯来文 - Ministry of Health

vitamed ltd,binyamina - povidone-iodine 10 % - solution - iodine products - disinfection of wounds, scratches, minor burns, skin infections in farm animals and pets. prevention of mastitis in cattle.

以色列 - 希伯来文 - Ministry of Health

megapharm ltd - fluorouracil - קרם - fluorouracil 50 mg / 1 g - pyrimidine analogues - antineoplastic agent to treat actinic keratosis multiple and superfacial basel cell carcinoma.

以色列 - 希伯来文 - Ministry of Health

bayer israel ltd - regorafenib - טבליות מצופות פילם - regorafenib 40 mg - regorafenib - regorafenib - stivarga is indicated for the treatment of patients with metastatic colorectal cancer (crc) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-vegf therapy, and if kras wild-type, an anti-egfr therapy.for the treatment of patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumors (gist) who have been previously treated with imatinib mesylate and sunitinib malate

以色列 - 希伯来文 - Ministry of Health

perrigo israel agencies ltd - benzoyl peroxide as hydrous 5 %w/w; clindamycin as phosphate 1 %w/w - gel - clindamycin - mild to moderate acne vulgaris, particulary inflammatory lesions.

以色列 - 希伯来文 - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

以色列 - 希伯来文 - Ministry of Health

cts chemical industries ltd, israel - valproic acid as sodium - סירופ - valproic acid as sodium 40 mg/ml ml - valproic acid - valproic acid - generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.

以色列 - 希伯来文 - Ministry of Health

allergan israel ltd - polyvinyl alcohol 1.4 %w/v; povidone 0.6 %w/v - eye drops - other ophthalmologicals - for the relief of dry eye symptoms and relief of discomfort and irritation caused by contact lens wear.

以色列 - 希伯来文 - Ministry of Health

cts chemical industries ltd, israel - trospium chloride - טבליות מצופות פילם - trospium chloride 20 mg - trospium

以色列 - 希伯来文 - Ministry of Health

eli lilly israel ltd - gemcitabine as hydrochloride - אבקה מיובשת בהקפאה להכנת תרכיז לאינפוזיה - gemcitabine as hydrochloride 200 mg/vial - pyrimidine analogues - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

以色列 - 希伯来文 - Ministry of Health

eli lilly israel ltd - gemcitabine as hydrochloride - אבקה מיובשת בהקפאה להכנת תרכיז לאינפוזיה - gemcitabine as hydrochloride 200 mg/vial - pyrimidine analogues - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.